Table 3 Characteristics of coronary risk factors and laboratory data according to OCT indicated plaque vulnerability

Male

16 (94.1)

9 (90.0)

46 (68.7)

Age

58.94 ± 10.23

50.10 ± 7.48

55.88 ± 11.93

Hypertension

10 (58.8)

3 (30.0)

32 (47.8)

Diabetes mellitus

12 (70.6)

7 (70.0)

18 (26.9)

Current smoking

10 (58.8)

7 (70.0)

40 (59.7)

Current drinking

4 (23.5)

2 (20.0)

12 (17.9)

Family history of CAD

2 (11.8)

1 (10.0)

13 (19.4)

Previous myocardial infarction

1 (5.9)

2 (20.0)

12 (17.9)

Previous PCI

7 (41.2)

4 (40.0)

10 (14.9)

BMI

28.38 ± 3.98

25.94 ± 1.92

24.23 ± 3.27

LDL-c (mmol/l)

2.53 ± 0.91

2.66 ± 0.78

2.41 ± 0.83

HDL-c (mmol/l)

0.93 ± 0.32

0.98 ± 0.23

0.98 ± 0.24

ApoA1(g/L)

1.03 ± 0.28

1.18 ± 0.34

1.09 ± 0.25

ApoB (g/L)

0.84 ± 0.26

0.78 ± 0.18

0.77 ± 0.19

TC (mmol/l)

3.61 ± 0.98

4.09 ± 0.79

3.65 ± 1.04

TG (mmol/l)

2.08 ± 1.02

2.09 ± 0.91

1.70 ± 0.90

Lp(a) (g/L)

219 (147,358)

134 (75,302)

191 (96,321)

Uric Acid (μmol/L)

348.79 ± 76.98

332.42 ± 59.12

327.72 ± 103.26

eGFR

112.59 ± 47.06

105.06 ± 22.26

106.76 ± 35.91

WBC

7.33 ± 1.46

7.54 ± 2.61

7.59 ± 2.62

PLT

223.12 ± 51.27

256.3 ± 114.34

230.84 ± 61.11

MPV

11.18 ± 0.69

11.04 ± 0.54

10.20 ± 1.00

MPV ≥ 10.5 fL

15 (88.2)

8 (80.0)

24 (35.8)

PCT (%)

0.25 ± 0.06

0.28 ± 0.11

0.23 ± 0.06

PDW

15.33 ± 1.2

15.14 ± 1.71

13.02 ± 2.35

HCT (%)

0.44 ± 0.05

0.44 ± 0.03

0.43 ± 0.04

RBC(10^¹²/L)

4.77 ± 0.46

4.86 ± 0.4

4.77 ± 0.48

HGB (g/L)

144.35 ± 16.82

146.5 ± 8.77

143.55 ± 16.21

EF

59.51 ± 10.15

58.13 ± 12.70

60.69 ± 7.23

HbA1c

7.47 ± 1.15

7.05 ± 1.10

7.20 ± 1.45

Clinical Diagnosis

 UAP

12 (70.6)

6 (60.0)

43 (64.2)

 NSTEMI

5 (29.4)

4 (40.0)

24 (35.8)

Statins

6 (35.3)

4 (40.0)

17 (25.4)

Aspirin

11 (64.7)

7 (70.0)

51 (76.1)

β-Blockers

7 (41.2)

2 (20.0)

23 (34.3)

ARB/ACEI

6 (35.3)

2 (20.0)

28 (41.8)

CCB

5 (29.4)

2 (20.0)

15 (22.4)